Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/3/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Ingmar Hoerr?

Ingmar Hoerr

Founder and Chief Executive Officer

CureVac GmbH

Direct Phone: +49 **** *******direct phone

Email: i***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

CureVac GmbH

210 Broadway Suite 201

Cambridge, Massachusetts,02139

United States

Company Description

Founded in 2000 as a spin-off from the University of T?bingen in Germany, CureVac is a technology leader in the development of drugs that are based on the molecule Messenger RNA (mRNA). The fully integrated biopharmaceutical company has more than 15 years of e...more

Background Information

Employment History

Administrative Coordinator

Wold Architects and Engineers


Behavioral Therapist

Lovaas Institute


Server

Keegan's Irish Pub


Research Assistant and Author

Dr. Cynthia Meyer, Counseling Skills


Counselor

Waukesha Family Ymca


MBA Fellow, Executive Ass. To Chief Executive Officer

EMC microcollections


Affiliations

High Level Group

Member


DN Capital

Advisory Board Member


Family Social Sciences Round Table

January 2013-May 2014 Active Member, Secretary 2013-2014 School Year


Education

MBA

Danube University


PhD

University of Tübingen


PhD

biology

Tuebingen University


Web References(129 Total References)


dievini.com : News 2017

www.dievini.com [cached]

CureVac's CEO, Ingmar Hoerr, Appointed by European Commission to High Level Group
CureVac, ... today announced that the European Commission has appointed CureVac's CEO, Ingmar Hoerr, Ph.D., as one of 15 members of the new High Level Group that will advise the Commission on how to strengthen support for breakthrough, market-creating innovation in Horizon 2020 and future research and innovation programs.


curevac.de: CureVac Establishes U.S. Operations in Cambridge, MA

www.curevac.com [cached]

Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, commented, "Expansion into the U.S. is an important step in CureVac's corporate and clinical growth as it will enable us to capitalize on the numerous research and business opportunities related to our industry-leading mRNA technology platform.


curevac.de: Company

www.curevac.com [cached]

In the late 1990s, Dr. Ingmar Hoerr, Co-founder and CEO of CureVac, made an unexpected discovery during his doctoral research in biology, which was contrary to the established scientific belief at the time: RNA, which was generally thought to be a very unstable biomolecule, could be administered directly into tissue as a therapeutic vaccine or agent once the biological properties of the molecule were appropriately modified.
Furthermore, complicated formulations or molecular packaging were not required to achieve these results. This discovery led to a new fundamental understanding of the potential of RNA to treat diseases and to generate prophylactic immunity. These fascinating possibilities prompted the company's three founders, Ingmar Hoerr, Steve Pascolo and Florian von der Mülbe, to found CureVac without investors during the difficult market environment of 2000.


curevac.de: CureVac Secures an Additional $29.5 Million From Two New Investors

www.curevac.com [cached]

Ingmar Hoerr, PhD, co-founder and CEO of CureVac stated, "We are happy to now have the support of two shareholders from the state of Baden-Württemberg, after having completed the last round of financing with five international investors.


curevac.de: CureVac presents clinical results of a Phase I/IIa trial in non-small cell lung cancer (NSCLC)

www.curevac.com [cached]

Dr. Ingmar Hoerr, CEO of CureVac, said "I believe these new results are excellent news for patients.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory